Medical device and capital-equipment receivables are a uniquely awkward B2B collection problem. Your buyers are sophisticated hospital systems, ambulatory surgery centers (ASCs), and physician groups — not insolvent one-offs. They pay slowly on purpose. Many have elaborate purchase-order workflows, contract-management systems, and procurement-controlled disputes. And a non-trivial subset use "clinical concern" framing to reduce legitimate invoices. This guide is a creditor-side playbook for California distributors facing those patterns.
Six Non-Payment Patterns We See Most Often
| Pattern | Description | Collection-file response |
|---|---|---|
| 1. PO-mismatch stall | AP refuses to pay invoices not tied to an open PO — but the PO expired. | Produce signed order confirmation, delivery receipt, and course-of-dealing evidence; assert §2-204 contract formation. |
| 2. "Clinical concern" reduction | Procurement asserts implants or consumables underperformed; offers 50% settlement. | Demand specific FDA-reportable events or written clinical protocol deviations; absence = pretext. |
| 3. Bundled-capital holdback | Hospital withholds payment on consumables until capital install punchlist completed. | Separate consumables claim under §2-709; capital under §2A-529 if leased. |
| 4. Group-purchasing-organization (GPO) price dispute | Buyer claims GPO contract pricing should apply, not distributor list. | Produce GPO roster, tier-membership proof, and price-list matrix; often GPO pricing doesn't apply. |
| 5. Ownership/successor dispute | ASC was sold; new owner denies liability. | CCC §2553/§2555 successor liability; §1060 bulk-sale analysis if asset transfer. |
| 6. 90+ day "working on it" limbo | Contact responds cordially, never escalates payment. | Escalate to CFO/General Counsel; §337a account-stated demand; Day 16 pre-filing notice. |
California Legal Framework
Most medical device transactions fall under CCC Article 2 (sale of goods) or Article 2A (leases for capital equipment). Supporting provisions include:
- CCP §337 — 4-year limitations on written contracts. Governs written POs and master supply agreements not covered by §2-725.
- CCP §337a — Open book account, 4 years from last entry. Excellent tool against hospitals with multi-invoice running ledgers.
- CCC §2-725 — 4-year limitations on sale of goods. Runs from tender, not from invoice date.
- CCC §2-709 — Action for the price. Available where goods are accepted, lost after risk of loss passed, or cannot be resold at reasonable price.
- CCC §2-706 — Seller's resale. Available for unaccepted or revoked implantables/capital.
- CCC §2-710 — Seller's incidental damages. Return shipping, re-stocking, storage.
- Civ. Code §3287/§3289 — Prejudgment interest. 10% on liquidated sum from due date.
- Civ. Code §1717 — Reciprocal attorney's fees. Standard in distributor master agreements.
- B&P §17200 — Unfair competition. Where a hospital system has a pattern of invoice reductions.
- CCC §9103/§9324/§9502 — PMSI in capital equipment. Perfect UCC-1 within 20 days of delivery for super-priority.
- Civ. Code §§2793, 2814 — Guaranty. Enforceable against physician-owners where signed.
- Civ. Code §3439 — UVTA. Where ASC transfers assets to a new entity without fair consideration.
HIPAA note: A distributor's collection file does not contain PHI. Purchase orders, model numbers, serial numbers, and invoice amounts are commercial data. Collection communications should be addressed to AP and Contract Management, not clinical staff, but HIPAA does not bar the enforcement of legitimate B2B receivables.
Five Master-Agreement Clauses Every Distributor Should Use
- Net-30 with late fee: 1.5%/month service charge; expressly enforceable under §3289 when stated.
- Price-list governs absent signed GPO tier confirmation: Forecloses retroactive GPO-pricing disputes.
- PMSI grant language + authorization to file UCC-1: Enables §9324 super-priority on capital.
- §1717 bilateral attorney's-fees clause: "The prevailing party shall recover reasonable attorney's fees."
- Physician-owner continuing guaranty for ASCs under 5 years old: Critical for newer facilities with limited retained earnings.
Case Study — $247,000 Surgical Robot Consumables
A California-headquartered robotic surgery consumables distributor was owed $247,000 from a multi-site ASC operator across 14 invoices spanning 11 months. The ASC operator disputed only two invoices (total $18,400) on quality grounds but withheld the entire AR pending "review." Our file:
- Produced Stripe ledger and order-portal order-confirmation trail;
- Demanded written FDA-reportable event list for quality-disputed units — none existed;
- Served §337a open-book-account demand citing continuous ledger entries;
- Filed a UCC-1 PMSI on the remaining on-site consumables;
- Day 16 pre-filing package attached draft complaint with §2-709/§3287/§1717 counts.
Resolution: Settled Day 22 at $228,600 (92.6% of face) plus interest; fee $34,290 under 15% contingency. Traditional agency at 33% would have cost $75,438 — client saved $41,148.
30-Day Demand and Escalation — Medical Device Overlay
- Day 0: Demand letter addressed to AP, CC Contract Management and CFO; attaches invoice-by-invoice ledger and delivery signatures.
- Day 3 AI call: Script navigates AP phone tree, documents contact name and direct line; requests escalation commitment.
- Day 5: Payment-plan offer with scheduled wire instructions; invokes GPO tier verification if raised.
- Day 7 AI call: Targets CFO or Controller; escalates settlement framing.
- Day 12 AI call: Post-deadline final-chance call with written settlement outline.
- Day 14 attorney review: UCC-1 PMSI filed if capital remains on-site; §9609 self-help analysis if peaceful.
- Day 16: Draft complaint with §2-709, §337a, §3287, §1717, §17200 counts attached.
- Day 25 filing: Concurrent RFA and RFP narrowly targeted at GPO contract production.
Fee Math — Common Medical Device AR Sizes
| Recovered amount | Traditional (33%) | LegalCollects (15%) | Client savings |
|---|---|---|---|
| $45,000 (consumables back-order) | $14,850 | $6,750 | $8,100 |
| $120,000 (imaging service contract) | $39,600 | $18,000 | $21,600 |
| $340,000 (surgical capital install) | $112,200 | $51,000 | $61,200 |
| $850,000 (multi-site robotics consumables) | $280,500 | $127,500 | $153,000 |
Five Likely Defenses and Rebuttals
| Defense | Rebuttal |
|---|---|
| "No open PO" | §2-204 formation by conduct; delivery acceptance; prior course of dealing. |
| "Clinical concern / product failure" | Demand FDA MDR or written clinical incident report; absence = pretext. |
| "GPO contract pricing applies" | Produce GPO roster; confirm tier; apply GPO only where contract by its terms applies. |
| "ASC was sold — not our debt" | Successor liability; UVTA if asset transfer without fair consideration. |
| "Still under review" | §337a account-stated demand converts ledger to stated account; §3287 interest accrues regardless. |